Vitamin A and E prices keep sliding as oversupply hits broader market
Vitamin A and E prices continue to decline across key regions, reflecting ongoing market weakness. Ample supply and cautious buying have led to subdued trading activity for most vitamins. While Vitamin D3 remains stable at higher price levels, other segments face growing downward pressure.
The market outlook for Q3 remains uncertain, with buyers hesitant to commit long term.
In partnership with Feed Additive Prices
Vitamin E 50%
This week, most regions are witnessing a consistent trend of declining prices. The only update has come from BASF, which announced the restart of its vitamin A500 operation, while there have been no developments regarding vitamin E. The market continues to exhibit signs of weakness, with gradual price reductions across all major areas. Only the USA market seems relatively stable. Although buyers have successfully secured enough contracts to cover part of the third quarter, they are taking a cautious approach when it comes to committing to longer-term agreements.
Vitamin A 1000
BASF has recently announced the lifting of the Force Majeure on Vitamin A 500, although there has been no update regarding Vitamin A 1000. So far, market reactions have been minimal, and overall trends indicate a continued decline in prices across all major regions. While supply remains abundant, demand is currently subdued, with only a fraction of the third quarter’s volume contracted.
Vitamin D3 500
Price levels are currently stable, remaining relatively high, leading market participants to speculate on the duration of this trend. Although there are occasional indications of a slight decline, these do not signify any significant changes. Overall, prices continue to be elevated, and availability remains constrained in many areas, with a substantial number of contracts for the third quarter already secured.
D-Calpan
The market remains largely stable yet somewhat subdued, with trading activity in many areas declining and prices staying low. An oversupply of material and available capacity appears to be exerting downward pressure on sales across all key regions. Currently, buyers are adopting a cautious strategy, having only secured a fraction of Q3.
Vitamin B3
The market remains largely stable with prices at lower levels, although some suppliers are eager to increase their volume by offering even more competitive prices; however, due to the well-saturated market, this does not result in significant sales. Buyers are taking a cautious approach at present, and only a portion of the third quarter has seen contracts finalised.
